Could ketamine be a fast-acting lifeline for suicidal teens and young adults?
NCT ID NCT04763343
First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 2 times
Summary
This study tests whether ketamine, given as an IV infusion, can quickly lower severe suicide risk in young people aged 14 to 30 who have just attempted suicide. Participants receive either ketamine or a placebo while in the hospital, plus weekly therapy sessions. The goal is to see if ketamine helps reduce suicidal thoughts faster and keeps patients engaged in follow-up care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUICIDE, ATTEMPTED are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Cleveland Clinic
RECRUITINGCleveland, Ohio, 44195, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a blood test spot teen suicide risk?
- Veterans helping veterans: Peer-Led program aims to prevent suicide in those with serious mental illness
- Can a sleep app help save teens from suicide?
- Giving patients the keys: Self-Controlled hospital stays may curb forced admissions
- Short therapy shows promise in preventing repeat suicide attempts
- ER docs get a suicide risk score: will it save lives?